These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 29802544
1. Dihydroergotamine inhibits the vasodepressor sensory CGRPergic outflow by prejunctional activation of α2-adrenoceptors and 5-HT1 receptors. González-Hernández A, Lozano-Cuenca J, Marichal-Cancino BA, MaassenVanDenBrink A, Villalón CM. J Headache Pain; 2018 May 25; 19(1):40. PubMed ID: 29802544 [Abstract] [Full Text] [Related]
2. Activation of 5-HT1B receptors inhibits the vasodepressor sensory CGRPergic outflow in pithed rats. González-Hernández A, Muñoz-Islas E, Lozano-Cuenca J, Ramírez-Rosas MB, Sánchez-López A, Centurión D, Ramírez-San Juan E, Villalón CM. Eur J Pharmacol; 2010 Jul 10; 637(1-3):131-7. PubMed ID: 20385119 [Abstract] [Full Text] [Related]
3. The 5-HT(1) receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), subtypes. González-Hernández A, Manrique-Maldonado G, Lozano-Cuenca J, Muñoz-Islas E, Centurión D, Maassen VanDenBrink A, Villalón CM. Eur J Pharmacol; 2011 Jun 01; 659(2-3):233-43. PubMed ID: 21473863 [Abstract] [Full Text] [Related]
4. The role of α1- and α2-adrenoceptor subtypes in the vasopressor responses induced by dihydroergotamine in ritanserin-pretreated pithed rats. Rivera-Mancilla E, Avilés-Rosas VH, Manrique-Maldonado G, Altamirano-Espinoza AH, Villanueva-Castillo B, MaassenVanDenBrink A, Villalón CM. J Headache Pain; 2017 Oct 11; 18(1):104. PubMed ID: 29022279 [Abstract] [Full Text] [Related]
5. Functional Characterization of the Prejunctional Receptors Mediating the Inhibition by Ergotamine of the Rat Perivascular Sensory Peptidergic Drive. González-Hernández A, Marichal-Cancino BA, Lozano-Cuenca J, MaassenVanDenBrink A, Villalón CM. ACS Chem Neurosci; 2019 Jul 17; 10(7):3173-3182. PubMed ID: 30695640 [Abstract] [Full Text] [Related]
6. Pharmacological analysis of the inhibition produced by moxonidine and agmatine on the vasodepressor sensory CGRPergic outflow in pithed rats. Rubio-Beltrán E, Labastida-Ramírez A, Hernández-Abreu O, MaassenVanDenBrink A, Villalón CM. Eur J Pharmacol; 2017 Oct 05; 812():97-103. PubMed ID: 28694067 [Abstract] [Full Text] [Related]
12. Role of 5-HT7 receptors in the inhibition of the vasodepressor sensory CGRPergic outflow in pithed rats. Cuesta C, García-Pedraza JÁ, García M, Villalón CM, Morán A. Vascul Pharmacol; 2014 Oct 05; 63(1):4-12. PubMed ID: 25179247 [Abstract] [Full Text] [Related]
15. Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors. Villalón CM, De Vries P, Rabelo G, Centurión D, Sánchez-López A, Saxena P. Br J Pharmacol; 1999 Feb 05; 126(3):585-94. PubMed ID: 10188968 [Abstract] [Full Text] [Related]
16. Olcegepant blocks neurogenic and non-neurogenic CGRPergic vasodepressor responses and facilitates noradrenergic vasopressor responses in pithed rats. Avilés-Rosas VH, Rivera-Mancilla E, Marichal-Cancino BA, Manrique-Maldonado G, Altamirano-Espinoza AH, Maassen Van Den Brink A, Villalón CM. Br J Pharmacol; 2017 Jul 05; 174(13):2001-2014. PubMed ID: 28369749 [Abstract] [Full Text] [Related]
20. The α2-adrenoceptors mediating inhibition of the vasopressor sympathetic outflow in pithed rats: pharmacological correlation with α2A, α2B and α2C subtypes. Villamil-Hernández MT, Alcántara-Vázquez O, Sánchez-López A, Centurión D. Eur J Pharmacol; 2013 Oct 15; 718(1-3):245-52. PubMed ID: 24028939 [Abstract] [Full Text] [Related] Page: [Next] [New Search]